Podcasts about hdv

From the 2024 International Hepatitis B virus meeting in Chicago IL, Rich Condit speaks with Stephan Urban about his career working on HBV and HDV, and his philanthropy. Host: Rich Condit Guest: Stephan Urban Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV ASV 2025 Hepatitis delta: recent advances (Hepatology) Bulevirtide for HBV and HDV (Lancet Inf Dis) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis. However, hepatitis is often caused by a virus. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. ​Hepatitis D, also known as “delta hepatitis,” is a liver infection caused by the hepatitis D virus (HDV). Hepatitis D only occurs in people who are also infected with the hepatitis B virus. Hepatitis D is spread when blood or other body fluids from a person infected with the virus enters the body of someone who is not infected. Hepatitis D can be an acute, short-term infection or become a long-term, chronic infection. Hepatitis D can cause severe symptoms and serious illness that can lead to life-long liver damage and even death. People can become infected with both hepatitis B and hepatitis D viruses at the same time (known as “coinfection”) or get hepatitis D after first being infected with the hepatitis B virus (known as “superinfection”). There is no vaccine to prevent hepatitis D. However, prevention of hepatitis B with hepatitis B vaccine also protects against future hepatitis D infection. ​Hepatitis E is a liver infection caused by the hepatitis E virus (HEV). HEV is found in the stool of an infected person. It is spread when someone unknowingly ingests the virus – even in microscopic amounts. In developing countries, people most often get hepatitis E from drinking water contaminated by feces from people who are infected with the virus. In the United States and other developed countries where hepatitis E is not common, people have gotten sick with hepatitis E after eating raw or undercooked pork, venison, wild boar meat, or shellfish. In the past, most cases in developed countries involved people who have recently traveled to countries where hepatitis E is common. Symptoms of hepatitis E can include fatigue, poor appetite, stomach pain, nausea, and jaundice. However, many people with hepatitis E, especially young children, have no symptoms. Except for the rare occurrence of chronic hepatitis E in people with compromised immune systems, most people recover fully from the disease without any complications. No vaccine for hepatitis E is currently available in the United States. (credits CDC)

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss best practices in hepatitis B virus (HBV) care, including: 2023 CDC HBV screening recommendationsSummary of guideline recommendations for hepatitis delta virus (HDV) screening Use of HDV reflex testing to avoid loss to follow-up2024 WHO HBV treatment recommendations, including recommendations for pregnant persons Presenters:Patricia D. Jones, MD, MSCRAssociate Professor of Clinical MedicineDirector of Clinical Operations-HepatologyDivision of Digestive Health and Liver DiseasesDepartment of MedicineUniversity of Miami Miller School of MedicineSylvester Comprehensive Cancer CenterMiami, FloridaMindie H. Nguyen, MD, MAS, AGAF, FAASLDProfessor of Medicine (GI & Hepatology,Liver Transplant)Professor of Epidemiology & Population Health(by Courtesy)Director of Hepatology ClerkshipFaculty Search LENS Advocates,Stanford Department of MedicineFaculty Fellow, Stanford Center for Innovationin Global HealthMember, Stanford Cancer Institute, Maternal &Child Health Research Institute, & Stanford Bio-CStanford, CaliforniaPast Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)28th President: The International Association for the Study of the Liver (IASL)Jennifer Wild, MS, RN, OCNClinical Nurse – GI Medical OncologyUCSF Cancer CenterSan Francsico, CaliforniaLink to full program: https://bit.ly/4j973TNDownloadable slides: https://bit.ly/3WQkIWlGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including:The importance of patient education along the care continuumEnsuring smooth transitions of care and communication between medical teamsScreening hepatitis delta in persons with chronic hepatitis BManaging hepatitis delta, including considerations for clinical trialsPromoting patient advocacyPresenter: Nancy Reau, MDProfessor of Medicine Chief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: bit.ly/3SrMuGOGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:Updated CDC recommendations for one-time universal screening for HBVAddressing patient-, provider-, and system-level barriers to universal HBV screeningBest practices for implementation of HDV screeningPresenters:Douglas Dieterich, MDDirector, Institute for Liver MedicineProfessor of MedicineDivision of Liver DiseasesMount Sinai School of MedicineNew York, New YorkCamilla S. Graham, MD, MPHCo-Director, Viral Hepatitis ClinicDivision of Infectious DiseasesBeth Israel Deaconess Medical CenterHarvard Medical SchoolBoston, MassachusettsRobert Wong, MD, MS Clinical Associate ProfessorDivision of Gastroenterology and HepatologyStanford University School of MedicinePalo Alto, CaliforniaLink to full program:https://bit.ly/3TuqFHILink to the slides: https://bit.ly/4atS42z

Join the faculty as they take a deep dive into hepatitis delta (HDV) to:Shed light on the controversies surrounding this disease.Share their perspectives on the latest and most hotly debated recommendations.Discuss how these new recommendations will shape the future of research and patient care.FacultyThomas Berg (Moderator)Maurizia Brunetto (Faculty)Ohad Etzion (Faculty)Related episodes:EASL Studio S2E3: Interview with Stephan Urban – From bench to bedside: Process of developing the first HBV/HDV entry inhibitorEASL Studio S2E8: Treatment of HBV-HDV coinfection in the era of entry inhibitionAll EASL Studio Podcasts are available on EASL Campus.

In this episode, Stefan Zeuzem, MD, discusses new data on viral hepatitis presented at EASL 2023, including:Hepatitis B virusDurability of response with bepirovirsenHBsAg loss with siRNA VIR-2218 combined with either VIR-3434 (novel monoclonal antibody) or pegIFN-alfaHepatitis delta virus96-week follow-up of immediate vs delayed bulevirtideOff-treatment response for lonafarnib + ritonavir ± pegIFN-alfa Safety and efficacy outcomes with siRNA JNJ-3989 + nucleos(t)ide analogueHepatitis C virusCollaborative service at opiate substitution treatment clinic to improve linkage to care in IrelandNurse-led test-and-treat program to increase screening and diagnosis at female prisons in the United KingdomFIND-C study using machine learning to improve screening-to-diagnosis ratio using clinical factors and social determinants of healthPresenter:Stefan Zeuzem, MDProfessor of Medicine Chief, Department of Medicine JW Goethe University Hospital Frankfurt, GermanyLink to full program: https://bit.ly/3JQQj3J

In this episode, Robert S. Brown, Jr., MD, MPH; Nancy Reau, MD; and Eric, a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in older adults, including:Awareness of HBV and CHB in older adultsUpdated HBV screening and vaccination recommendationsMonitoring of renal and bone diseaseAdjustment of monitoring and treatment as a person with HBV agesPresenters: Robert S. Brown, Jr., MD, MPHVincent Astor Distinguished Professor of MedicineChief, Division of Gastroenterology and HepatologyWeill Cornell MedicineNew York, New YorkNancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisEric, person living with chronic hepatitis BLink to downloadable slides: please link to VM404 downloadable slides when readyLink to program: bit.ly/3L3Kz6l

Hepatitis D is the most severe form of viral hepatitis infection, but fortunately, new treatments are on the horizon.This EASL Studio discusses:Which patients should be treated.Currently available treatment options.Treatment combinations and duration.New treatments in development.FacultyProf. Heiner Wedemeyer (Moderator)Prof. Soo Aleman (Faculty)Prof. Pietro Lampertico (Faculty)Related episodes:S2E3: Interview with Stephan Urban – From bench to bedside: Process of developing the first HBV/HDV entry inhibitor.S2E8: Treatment of HBV-HDV coinfection in the era of entry inhibition.Midday Talks: HBV and HDV drug development – Where do we stand and where are we going?All EASL Studio Podcasts are available on EASL Campus.

In this episode, Tatyana Kushner, MD, MSCE, and Stefan Zeuzem, MD, address key considerations when screening, diagnosing, and treating patients with HDV, such as:Barriers to HDV screening, including limitations to AASLD guideline recommendationsUse of double reflex testing to improve HDV diagnosisConsiderations for repeat HDV testing in patients who are HBsAg positive who previously tested negative for HDVUpdated CDC recommendations for HBV screening for all adults using a triple panel test Staging advanced liver disease in patients with HDVIndications for HDV treatment, including patients with low ALT levels and advanced or progressive liver diseaseTreatment landscape for HDVPersonal experiences with use of pegylated interferon for HDV treatment, including considerations for use in patients with compensated cirrhosisUpdates on novel HDV therapies, including:Summary of efficacy data on bulevirtide from clinical trialsInterpretation of results from D-LIVR, a phase III trial assessing the safety and efficacy of lonafarnib Link to full program: bit.ly/3yp1Lxf

In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:Barriers to screening HDV screening based on patient risk factors Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)Reflex testing Availability of commercial testingMonitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNALimitations to evaluating advanced fibrosis in patients with HDVData on novel HDV therapies (eg, bulevirtide and lonafarnib)Extending HDV therapy (eg, peginterferon) based on treatment responseStopping rules (eg, HDV RNA negativity, HBsAg loss) for discontinuing HDV therapyFaculty:Maria Buti, MDProfessor of MedicineHospital Universitario Vall d'HebronBarcelona, SpainRichard H. Davis, PA-CSenior PAGastroenterologyUniversity of FloridaUF HealthGainesville, FloridaLink to full program: http://bit.ly/3yp1Lxf

In this episode, Coleman I. Smith, MD, and Lydia Tang, MBChB, discuss how to screen for hepatitis delta virus (HDV), including:Algorithm for evaluation of HDVDiagnosis of different stages of HDV infection Strategies to increase HDV testing rates Faculty:Coleman I. Smith, MDProfessor of MedicineHepatologistGeorgetown Transplant InstituteGeorgetown UniversityWashington, DCLydia Tang, MBChB Assistant ProfessorDepartment of Infectious DiseasesUniversity of Maryland School of MedicineInstitute of Human VirologyBaltimore, MarylandLink to full program:http://bit.ly/41oYawrFollow along with the slides at: http://bit.ly/3XW6m4g

In this episode, Nancy Reau, MD, and Lydia Tang, MBChB, discuss how to increase linkage to care rates for persons with hepatitis D virus, including:Updates on currently low rates of linkage to careBarriers preventing patients with HBV/HDV coinfection from engaging in careInterventions to increase retention in care for patients with HDV Faculty: Nancy Reau, MDProfessor of MedicineChief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisLydia Tang, MBChB Assistant ProfessorDepartment of Infectious DiseasesUniversity of Maryland School of MedicineInstitute of Human VirologyBaltimore, MarylandLink to full program: https://bit.ly/41oYawrFollow along with the slides at: https://bit.ly/3XW6m4g

Tophotel Today vom 08.02.2023 mit diesen Themen: 1. HDV: 10 Hospitality-Verbände auf dem "Branchentag der Profis" 2. Studie: 2023 könnte Rekord-Reisejahr werden 3. Fotostrecke: Designhotel feiert Debüt in den Alpen

Tophotel Today vom 24.01.2023 mit diesen Themen: 1. Tophotel 100-Tage-Check: Tina Brack: „Mein Ziel ist ein modernes Grandhotel“ 2. Fotostrecke: Luxuriöses Familienhotel im Montafon 3. Verbände: HDV baut Trainingsprogramm für Mitglieder aus

In this episode, Nancy Reau, MD, and Coleman I. Smith, MD, discuss the burden of undiagnosed hepatitis delta virus (HDV) infection and who should be tested, including:Epidemiology of HDV infectionClinical course of HDV infectionPopulations at high risk of HDV infectionGuidelines for HDV testingFaculty: Nancy Reau, MDProfessor of MedicineChief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisColeman I. Smith, MDProfessor of MedicineHepatologistGeorgetown Transplant InstituteGeorgetown UniversityWashington, DCLink to full program: https://bit.ly/3WmJnziFollow along with the slides at:https://bit.ly/3NpAYI1

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including:Hepatitis BPrevention of HBV vertical transmission when HBIg is unavailableTherapeutic vaccination for HBV cureAntiviral therapy to prevent HCC in patients with CHB in the indeterminate phaseHepatitis deltaHDV prevalence in ethnically diverse, urban, safety-net populationsBulevirtide ± pegIFN-α2a for chronic HDV in the French cATU studyBulevirtide monotherapy for patients with HDV and compensated cirrhosis in the HEP4Di studyHDV functional cure with lonafarnib-based therapyHepatitis CIntegrated community HCV service for PWUD: the ITTREAT studyHelios-3 study of treatment of people with HCV by specialists or nonspecialistsRisk of HCC after SVR in patients with HCVPresenter:Stefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine I JW Goethe University Hospital Frankfurt, GermanyFollow along with the downloadable slideset at: https://bit.ly/3FxIOwZLink to full program: https://bit.ly/3Y1tD6f

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:Novel therapeutics for HBVHCV management strategiesHDV screening and linkage to careFatty liver disease in persons with viral hepatitisUse of statins to decrease morbidity and mortality in persons with liver diseasePresenter:Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate DirectorSolid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisLink to full program: https://bit.ly/3Y1tD6f

Juegos y experiencias lúdicas de estas dos últimas semanas, con las confesiones de Clint sobre un tercer Clinteo a un juego, las apuestas están abiertas para ver cuánto tarda acaba en el HdV, por cierto, este Essen, de momento una castaña ¿no? 00:00:00 - Inicio 00:03:34 - 18xx Con en Asturias 00:10:07 - Imperial Struggle 00:25:25 - Confesiones de Clint 00:34:27 - El tamaño estándar de las cajas ahora es 4XL 00:43:17 - Kickstarter 00:58:57 - Thiefdom 01:22:26 - Virtù 01:38:34 - Marvel Dice Throne 01:54:13 - Aegean Sea

Neena and Tracey discuss ARKK, dividend and energy ETFs. (1:00) - Are Investors Still Following Cathie Wood's Funds? (11:15) - Finding the Right ETF Strategy For Your Portfolio (21:50) - Dividend ETFs Growth In Popularity  (26:15) - Does Energy Sector's Strong Performance Translate To ETF Fund Flows? (33:30) - Episode Roundup: ARKK, SARK, TARK, SCHD, HDV, STRV, IYE  Podcast@Zacks.com

You can think of the “D” in HDV as standing for difficult, disadvantaged, and dangerous. Hepatitis delta virus (HDV) is difficult to diagnose, is often diagnosed in disadvantaged patient populations, and leads to dangerous sequelae.Listen as Dr. Kosh Agarwal and Dr. Graham R. Foster and discuss challenges and opportunities for linking patients to care after a positive test for HDV.Presenters:Kosh Agarwal, MDConsultant Hepatologist and Transplant PhysicianInstitute of Liver StudiesKing's College Hospital NHS Foundation TrustLondon, United KingdomGraham R. Foster, FRCP, PhDProfessor of HepatologyThe Liver UnitConsultant HepatologistQueen Mary University of LondonLondon, United KingdomLink to full program:https://bit.ly/3tlxa0H

In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from EASL 2022, including:Novel HBV therapeutics, including the REEF-2, B-Clear, and SAVE-1 studiesHBV cure from the Everest Project in ChinaHDV therapeutics from MYR301 and a study of bulevirtide in patients with cirrhosis and portal hypertensionHCV retreatment in patients with prior direct-acting antiviral therapy failurePresenter: Stefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine I JW Goethe University Hospital Frankfurt, GermanyFollow along with the downloadable slideset at:https://bit.ly/3yJAruDLink to full program: https://bit.ly/3AjCNBC

In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:Novel therapeutics for HBVTherapeutic vaccination for HBVEmerging treatment options for HDVHCV care cascadeHCC monitoring after HCV curePresenter: Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisFollow along with the downloadable slideset at: https://bit.ly/3yJAruDLink to full program:https://bit.ly/3IeUapm

When markets plummet like they have this year, investors want to grab onto something—anything—that isn't in free-fall. High-dividend exchange-traded funds, with their exposures to the energy and utilities sectors, have emerged as a rare bright spot, or at least a less-dim one. They've seen $25 billion in inflows already, which is a record—one that could double by the end of the year.  On this episode, Eric and Joel speak with Todd Rosenbluth, head of research at VettaFi, and reporter Suzanne Woolley about a category of ETFs punching above their weight. They discuss some of the noteworthy ETFs, including $VYM, $DVY, $HDV, $DHS; analyze holdings and performances, and share how investors can dabble with these made-for-the-moment products. See omnystudio.com/listener for privacy information.

When markets plummet like they have this year, investors want to grab onto something—anything—that isn't in free-fall. High-dividend exchange-traded funds, with their exposures to the energy and utilities sectors, have emerged as a rare bright spot, or at least a less-dim one. They've seen $25 billion in inflows already, which is a record—one that could double by the end of the year.  On this episode, Eric and Joel speak with Todd Rosenbluth, head of research at VettaFi, and reporter Suzanne Woolley about a category of ETFs punching above their weight. They discuss some of the noteworthy ETFs, including $VYM, $DVY, $HDV, $DHS; analyze holdings and performances, and share how investors can dabble with these made-for-the-moment products.  See omnystudio.com/listener for privacy information.

In this episode of ETF Battles, Ron DeLegge @ETFguide referees an audience requested bout between a pair of high dividend ETFs from Blackrock's iShares ETF family (HDV) and Vanguard (VYM). Program judges Cinthia Murphy with ETF Think Tank and Todd Rosenbluth with ETF Trends judge this bout, sharing their investing research insights. Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!*********ETF Battles is sponsored by: Direxion Daily Leveraged & Inverse ETFs. Know the risks. Proceed Boldly. Visit http://www.Direxion.com 

Hepatitis delta virus (HDV) is the most severe form of viral hepatitis, yet many patients go undiagnosed. Increasing HDV awareness is an important step to correct this and ensure that at-risk patients receive screening and then treatment and monitoring following a positive test. Hear Grace LH Wong, MD, and Ming-Lung Yu, MD, PhD, discuss a call to action to increase healthcare professional and patient awareness of HDV. Presenters: Grace LH Wong, MDProfessorDirector, Medical Data Analytics Centre (MDAC)Deputy Director, Center for Liver HealthAssistant Dean (Learning Experience), Faculty of MedicineThe Chinese University of Hong KongHonorary ConsultantDivision of Gastroenterology and HepatologyDepartment of Medicine and TherapeuticsPrince of Wales HospitalHong KongMing-Lung Yu, MD, PhDChair ProfessorHepatobiliary DivisionDepartment of Internal Medicine and Hepatitis CenterKaohsiung Medical UniversityVisiting StaffHepatobiliary DivisionDepartment of Internal MedicineKaohsiung Medical University HospitalKaohsiung City, TaiwanLink to full program: https://bit.ly/3tlxa0H

Tophotel Today vom 05.04.2022 mit diesen Themen: 1. HDV-Frühjahrstagung: Neues Leitbild vorgestellt 2. Traube Tonbach: Endspurt beim Neubau 3. Althoff Hotels: Urban Loft eröffnet im Sommer in Berlin

"When Hepatitis Infection Is Double Trouble: The Need for Proactive Screening for HDV"

"When Hepatitis Infection Is Double Trouble: The Need for Proactive Screening for HDV"

"When Hepatitis Infection Is Double Trouble: The Need for Proactive Screening for HDV"

"When Hepatitis Infection Is Double Trouble: The Need for Proactive Screening for HDV"

In this episode,  Heiner Wedemeyer, MD, discusses HDV epidemiology beyond the United States, the features of HDV/HBV pathology, insights into screening and diagnostic approaches, key aspects of disease staging, new treatment options, and important remaining clinical questions regarding optimal management of HDV.Presenter:Heiner Wedemeyer, MDProfessor and ChairmanDepartment of Gastroenterology, Hepatology and EndocrinologyHannover Medical SchoolHannover, GermanyContent based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences, Inc. and developed in collaboration with the American Liver Foundation. Link to full program:https://bit.ly/3KmJvZt

James and Guillaume Boudet, the winemaker for HdV in Napa, California, discuss the differences between the 2018 and 2019 vintages."In the long run we'll see which one is is better than the other one," Guillaume says. "I think '18 might be up there, but also '19 has more of this approachable charm almost from the get-go. But '18 was so easy – it was a very compact vintage but we were able to pick everything when we wanted to pick and still be able to retain a lot of freshness and aromas in the wines... so time will tell but definitely '18 is is one of the top three vintages that we've had in in the past 10-15 years, definitely."They also talk about the 2020 vintage and how the fires affected HdV's operations.

Hepatitis delta virus (HDV) is the most severe form of viral hepatitis and warrants new treatment options for better efficacy and tolerability. In part 2 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss their thoughts on new and emerging treatment options for HDV and rational use of these new agents. Their discussion includes:Assembly inhibitors (eg, lonafarnib)Entry inhibitors (eg, bulevirtide)Interferon lambdaNucleic acid polymersSmall interfering RNA (siRNA) agentsPresenters: Heiner Wedemeyer, MDProfessor and ChairmanDepartment of Gastroenterology, Hepatology, and EndocrinologyHannover Medical SchoolHannover, GermanyCihan Yurdadin, MDProfessor and Chief Department of Gastroenterology and HepatologyKoç University Medical SchoolIstanbul, TurkeyLink to full program:https://bit.ly/365VUlG

Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss their thoughts on serologic testing for both HDV and HBV and steps to take in monitoring, treating, and reassessing HBV in patients coinfected with HDV.Presenters:Heiner Wedemeyer, MDProfessor and ChairmanDepartment of Gastroenterology, Hepatology, and EndocrinologyHannover Medical SchoolHannover, GermanyCihan Yurdaydin, MDProfessor and Chief, Department of Gastroenterology and HepatologyKoç University Medical SchoolIstanbul, TurkeyLink to full program:https://bit.ly/365VUlG

Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem discuss their thoughts on up-and-coming agents for treating HDV, and explore what questions need answering to most effectively use currently available and emerging therapies, which include:BulevirtideInterferon λLonafarnibPresenters:Nancy Reau, MDProfessor of MedicineChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisStefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine IJW Goethe University HospitalFrankfurt, GermanyLink to full program:https://bit.ly/3tlxa0H

Мы не знаем, ждали ли вы этого выпуска, но его стоило подождать! Пристегнитесь, выдохните и берегите свои тазовые донья — здесь очень смешно. Эпизод позволит вам узнать наконец, как:   - вовремя говорить и вовремя молчать - победить депрессию через центр разума в вашем сердце - стать «женщиной расслабляющей» - избавиться от мужских энергий и программы «Я сама» - не допустить разрастания в вас (женщине) яиц - не стать «депрессивной матерью» - удержать богатого мужчину и/или вернуть бывшего силой мысли - научиться наконец спать, когда спит ребенок!!111 - декодировать, чтобы волосы не были кудрявыми   Бонусы: история вед, дышащая полной грудью матка, накопительный эффект апельсинов и поиск логики в этом невероятном популярном дискурсе (спойлер: так и не нашли).   Партнер этого сезона — образовательная платформа Нетология. Сделать шаг к переменам и начать учиться тому, что вам интересно, можно по ссылке: http://netolo.gy/hAB По промокоду NIKAKOGO — скидка 10% на обучение в Нетологии (кроме курсов направлений Высшее образование, MBA и Lifestyle and hobby). Скидка суммируется с другими акциями на сайте. Промокод действует до конца мая 2022 года. Бесплатный курс «Диджитал-старт»: http://netolo.gy/hDv   Авиасейлс Ещё — это сервис для тех, кто хочет получать от путешествий еще больше: кэшбек в рублях, неформальные гайды, VIP-поддержку и скидки на ПЦР: https://i.avs.io/626zul(промокод НИКАКОГО)   Мы используем музыку Marimba Plus, The Way To Your Heart. Композитор — Лев Слепнер Наш звукорежиссер — Юрий Шустицкий   Наш сайт инстаграм-блог — @no.pravil.no имейл — no.pravil.no@gmail.com Это подкаст студии Либо/Либо

In this episode, Robert G. Gish, MD, and Pietro Lampertico, MD, PhD, share lessons learned in the care of patients coinfected with hepatitis B virus and hepatitis delta virus (HDV), including:Burden of HDV infectionChronic HDV infection and comorbiditiesImpact of COVID-19 on care of patients with chronic hepatitis BScreening for HDV and which assays to useScreening for viral hepatitis at a COVID-19 vaccination sitePresenters:Robert G. Gish, MD, FAASLD, AGAF, FASTProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaClinical ProfessorUniversity of Nevada Reno School of MedicineReno, NevadaUniversity of California Skaggs School of Pharmacy and Pharmaceutical SciencesSan Diego, CaliforniaMedical DirectorHepatitis B FoundationWashington, DCPietro Lampertico, MD, PhDProfessor of GastroenterologyDirector, Division of Gastroenterology and HepatologyIRCCS Ca Granda Policlinico HospitalUniversity of MilanMilan, ItalyFollow along with the slides at:https://bit.ly/3HQ6dZ5Link to full program: https://bit.ly/3Bgyd5I

Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. In this episode, Maria Buti, MD, and Robert G. Gish, MD, discuss the prevalence and severity of hepatitis delta. Hear their personal experiences from the clinic and their call to action for universal screening of patients with hepatitis B for coinfection with hepatitis delta.Presenters:Maria Buti, MDProfessor of MedicineHospital Universitario Vall d'HebronBarcelona, SpainRobert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaMedical DirectorHepatitis B FoundationWashington, DCLink to full program:https://bit.ly/3E9xKSx

In this episode, Nancy Reau, MD, discusses new viral hepatitis data from AASLD 2021, including:HBV treatment in pregnancyOutcomes following HBV treatment withdrawal  Progress toward an HBV cureHCV implementation science and current status of the cascade of careHepatitis delta virus: understanding the clinical impactPhase III clinical trial updates for hepatitis delta virus, including data on bulevirtidePresenter:  Nancy Reau, MDProfessor of Medicine  Chief, Section of HepatologyAssociate Director, Solid Organ TransplantationRichard B. Capps Chair of HepatologyRush University Medical CenterChicago, IllinoisFollow along with the downloadable slideset at:https://bit.ly/3d6NQRVLink to full program:https://bit.ly/3lputrT

Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis. However, hepatitis is often caused by a virus. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. ​Hepatitis D, also known as “delta hepatitis,” is a liver infection caused by the hepatitis D virus (HDV). Hepatitis D only occurs in people who are also infected with the hepatitis B virus. Hepatitis D is spread when blood or other body fluids from a person infected with the virus enters the body of someone who is not infected. Hepatitis D can be an acute, short-term infection or become a long-term, chronic infection. Hepatitis D can cause severe symptoms and serious illness that can lead to life-long liver damage and even death. People can become infected with both hepatitis B and hepatitis D viruses at the same time (known as “coinfection”) or get hepatitis D after first being infected with the hepatitis B virus (known as “superinfection”). There is no vaccine to prevent hepatitis D. However, prevention of hepatitis B with hepatitis B vaccine also protects against future hepatitis D infection. ​Hepatitis E is a liver infection caused by the hepatitis E virus (HEV). HEV is found in the stool of an infected person. It is spread when someone unknowingly ingests the virus – even in microscopic amounts. In developing countries, people most often get hepatitis E from drinking water contaminated by feces from people who are infected with the virus. In the United States and other developed countries where hepatitis E is not common, people have gotten sick with hepatitis E after eating raw or undercooked pork, venison, wild boar meat, or shellfish. In the past, most cases in developed countries involved people who have recently traveled to countries where hepatitis E is common. Symptoms of hepatitis E can include fatigue, poor appetite, stomach pain, nausea, and jaundice. However, many people with hepatitis E, especially young children, have no symptoms. Except for the rare occurrence of chronic hepatitis E in people with compromised immune systems, most people recover fully from the disease without any complications. No vaccine for hepatitis E is currently available in the United States. (credits CDC)

Bei der Herbsttagung der Hoteldirektorenvereinigung Deutschland (HDV) vom 12. - 14. November in Hamburg spricht Verlagsleiter Jan Peter Kruse mit Jürgen Gangl, 1. Vorsitzender der HDV.

Tophotel Today vom 15.11.2021 mit diesen Themen: 1. HDV: 1. Vorsitzender Jürgen Gangl spricht von "Hintertür-Lockdown" 2. Dehoga appelliert an Politik, neuen Lockdown auszuschließen 3. Österreich: Lockdown für Ungeimpfte tritt in Kraft

In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.Stefan Zeuzem, MDProfessor of MedicineChief, Department of Medicine IJW Goethe University Hospital Frankfurt, GermanyContent based on a CME program supported by educational grants provided by AbbVie, Antios Therapeutics, and Gilead Sciences, Inc.To follow along, download the slides at:https://bit.ly/3rl8AeSLink to full program:https://bit.ly/3ky46QK

Tophotel Today vom 07.07.2021 mit diesen Themen: 1. Auch nach dem Restart hohe Umsatzverluste im Gastgewerbe 2. Dehoga Bayern fordert klare Perspektive für den Herbst 3. Fairmas Hotel Report: Kennzahlen im Juni erholen sich deutlich 4. Gütesiegel der HDV jetzt auch bei Fair Job Hotels

Tophotel Today vom 21.06.2021 mit diesen Themen: 1. 40 Jahre Hoteldirektorenvereinigung Deutschland 2. Neuigkeiten bei den Luxury Brands von Accor im Überblick 3. April 2021: Corona-Einschränkungen bremsen Erholung im Gastgewerbe

HDV is back again! After a couple of weeks off, the guys get a new addition to the show. Meet Lili, fellow radio graduate and longtime friend of Brock, Byron and Alex. The HDV crew has grown to 4 so enjoy the show! Enjoy this show on multiple platforms other than Spotify for this edition, music will be returning very soon!

Well it finally happened. This is Episode 100. Nothing special, just some talk segments. A bigger event will be planned but in all honesty we forgot that we were getting close. HDV is still going strong! Enjoy the show.

With a slightly delayed audio upload, the show is back on the air! The next 2 episodes (including this one) will just be the talk sections with no music, so we apologise in advance for that, but HDV is back, and better than ever.

With a slightly delayed audio upload, the show is back on the air! The next 3 episodes (including this one) will just be the talk sections with no music, so we apologise in advance for that, but HDV is back, and better than ever.

Hoy les hablaremos sobre supersticiones locas que rodean el mundo entero ¿Has pisado caca de perro? Porque la fortuna te ha traído un nuevo capítulo de HDV.

Die Sonderedition des So Geht Hotel Heute Podcasts geht in die siebte Gesprächsrunde und Marco Nussbaum begrüßt den stellvertretenden Vorstandsvorsitzenden der HDV (Hoteldirektorenvereinigung Deutschland e.V.) und den Geschäftsführer der Weissenhäuser Strand GmbH & Co. KG, David Depenau am Hörer. Optimist Depenau spricht über eingeleitete Corona-Maßnahmen, neue Prozessbeschreibungen und vorbereitete Hygienekonzepte zur Wiedereröffnung und bereitet spätestens durch seinen spontanen Elevator Pitch über den Ferienpark Weissenhäuser Strand Fernweh auf die Post-Corona-Zeit und Urlaub an der Ostsee.

The un-encapsidated TWiV Humans discuss finding hepatitis D virus-related sequences in birds and snakes, and fatal swine acute diarrhoea syndrome caused by a coronavirus of bat origin. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode European Virus Archive ASV early bird registrationends 15 May FDA approves Dengvaxia Divergent hepatitis D-like agentin birds(Viruses) Novel deltavirus in snakes(mBio) SADS-coronavirusin piglets (Nature) Hosts and sources of endemic human coronaviruses(Adv Virus Res) Image credit Letters readon TWiV 546 Timestamps by Jolene. Thanks! This episode is sponsored by the 2019 Chem/Bio Defense Science and Technology Conference. Are you working on innovative research that can shape the future of chemical or biological defense? Submit your abstract and present your work to more than 1,500 leaders from government, academia and industry. Visit www.cbdstconference.com for more details. Weekly Science Picks Alan - Plots of Data visualization tool Rich - How to control the brain; Meet UF Physician Kelly Foote, MD Dickson- Oceanix Kathy- Iceproofing large structures Vincent - Neanderthal Man: In Search of Lost Genomes by Svante Paabo Listener Pick Johyne- NYTimes Mag Lab (sorry, no link) Sheena - History of Vaccines by NPR Intro music is by Ronald Jenkees. Send your virology questions and comments to twiv@microbe.tv

The un-encapsidated TWiV Humans discuss finding hepatitis D virus-related sequences in birds and snakes, and fatal swine acute diarrhoea syndrome caused by a coronavirus of bat origin. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode European Virus Archive ASV early bird registrationends 15 May FDA approves Dengvaxia Divergent hepatitis D-like agentin birds(Viruses) Novel deltavirus in snakes(mBio) SADS-coronavirusin piglets (Nature) Hosts and sources of endemic human coronaviruses(Adv Virus Res) Image credit Letters readon TWiV 546 Timestamps by Jolene. Thanks! This episode is sponsored by the 2019 Chem/Bio Defense Science and Technology Conference. Are you working on innovative research that can shape the future of chemical or biological defense? Submit your abstract and present your work to more than 1,500 leaders from government, academia and industry. Visit www.cbdstconference.com for more details. Weekly Science Picks Alan - Plots of Data visualization tool Rich - How to control the brain; Meet UF Physician Kelly Foote, MD Dickson- Oceanix Kathy- Iceproofing large structures Vincent - Neanderthal Man: In Search of Lost Genomes by Svante Paabo Listener Pick Johyne- NYTimes Mag Lab (sorry, no link) Sheena - History of Vaccines by NPR Intro music is by Ronald Jenkees. Send your virology questions and comments to twiv@microbe.tv

Bob Geho, CEO, Diasome discusses the current treatments for diabetes and the nearly 100 year history of insulin.  He talks about the company's hepatocyte directed vesicle (HDV) nanotechnology that can be added to any insulin to lessen the instances of high and low blood sugar levels in people with diabetes.  HDV nanotechnology can be added to any insulin to improve its safety and efficacy by targeting specific organs and in this case, restoring the liver's natural role in blood glucose control. #Type1Diabetes  #Type2Diabetes  #Diabetes #Insulin @diasome Diasome.com

Hosts: Vincent Racaniello, Rich Condit, Dickson Despommier, Alan Dove, and Kathy Spindler The complete TWiV team reviews identification of the cell receptor for hepatitis B and D viruses, and the cell enzyme that cleaves the genome-linked protein from picornaviral RNA. Links for this episode: HBV and HDV cell receptor (eLIFE) Getting to grips with hepatitis (eLIFE) Sodium taurocholate Poliovirus hijacks DNA repair enzyme (PNAS) Letters read on TWiV 210 Weekly Science Picks Rich - Vendée GlobeDickson - Earth at nightAlan - Trophée Jules VerneKathy - Science cookiesVincent - Trilobite Glassworks Listener Pick of the Week Ken - Spanish flu pandemic model (teacher's guide)Jim - Santa Cruz Science Communication Program (also see SHERP) Send your virology questions and comments (email or mp3 file) to twiv@twiv.tv

Review of the Sony XDCAM EX-1 Ergonomics, slow motion and mediaI recorded the review of this camera before I began the One a Day series and I'm not going to hold on to it until December. Since making this recording I've been able to use this camera several times and it's been a real pleasure.It's well designed and I believe that's why it hasn't been difficult to learn how to use it. The media is easy to use, really not that much different from the P2, but it feels more comfortable to work with. I mentioned the Hoodman in this episode as a low cost replacement for the SxS from Sony. Kensington also has a low cost alternative you should look into.CDIAOver/Under crank (slow motion)Keystone CopsCreative Cow Pros and Cons between P2 and SxSWikipedia article on HDV and different screen resolutionsThorough review of the EX-1

Sam Barry, author of "How to Play the Harmonica" will make you laugh, inspire you to try new things, and yes—teach you how to play. As a former minister, reporter, activist, bohemian, artist and musician Sam Barry knows a great many things about life – and playing the harmonica. Barry currently works as a marketing and promotions manager at HarperOne and plays the harmonica in The Rock Bottom Remainders with his brother Dave Barry. He and his partner, Kathi Kamen Goldmark, write the national column “The Author Enabler” in BookPage. WWW.REDROOM.COM/AUTHOR/SAM-BARRY Also on today's show Christopher Dalrymple, two-time Emmy-winning filmmaker 1980, The War Machine: The Defense of the United States, CBS Reports, and 1990, Interview with Marlon Brando, "Saturday Night with Connie Chung") His new Film "And Then..., a Cassevettes-style black comedy shot in HDV about a former leading man who is given a second chance at stardom, but his obligations trump opportunity and twists, turns, and murders abound. www.dalrymplepictures.com also guest John Galasso Producer and Anton Evangelista,Actor/Director appeared in"The Cotton Club," "Prizzi's Honor," TV's "Law and Order," "Search for Tomorrow," "As the World Turns" and in Ron Howard's "Ransom" with Mel Gibson. In 1995, he produced and directed his first short film "Beyond Reason" It wasn't until after Anton's completion of his film that the two seriously discussed laughing -- an idea for a movie about laughing and healing. A subject John was well aware of, after experiencing a back injury that nearly crippled him. "The idea of laughing towards better health appealed to me. I wish I knew what I know now back then." The two agreed and "Just Laugh" would be the documentary they would make, exploring the many gifts of laughter. www.justlaugh.org

Listening to this show and trying to reach from what I know to what the least informed person knows is very difficult. It's hard to record a session of me talking off the cuff, just using notes, because I end up using a lot of shorthand without explain things. I need a glossary.I don't have one, but I have included some brief explanations of some of the video codewords I've mentioned in passing, in this show. If you follow the links you'll find more thorough descriptions. It can get pretty thick, but it really helps to know these things.This episode begins with a recent revelation about my goals and future direction as a filmmaking professional. I've also included details I've gleaned from blogs, podcasts and presentations at a recent meeting of the Boston FCP User's Group.This has been a busy summer of media events. I've attended Podcamp Boston 4, Podcaster's Across Borders in Kingston Ontario, the Boston Media Makers get together which meets in Jamaica Plains the first Sunday of every month and the annual Avid Summer BBQ.I wanted to attend Podcamp Montreal, which takes place in a couple weeks, but I think I need to stay at home. There is also a Podcamp New Hampshire, taking place in Portsmouth in November.It was at the Boston Final Cut Pro User's group that took place in August that I saw Philip Hodgetts present an overview of new features for FCP7. I've also included information I've gleaned from Apple's FCS site and the Digital Production Buzz. You can also find video tutorials online that demonstrate what the new features are in all applications within the suite.One of the warm up presentations that I thought was particularly noteworthy was for Mocha for FCP from Imagineer Systems. Check out the link above for videos that explain image tracking and rotoscoping in a way that will quickly make sense. Here's my abbreviated version:Imagine you're seeing a movie and there's a scene at a football stadium. There's a huge video screen that shows instant replays and and short commercials. The people who made that movie didn't record the information on that screen when they shot the footage of the stadium, they inserted their own footage on the screen in the editing suite. Maybe an advertisement for a product that they're getting paid to place in the movie.In a still image you can select the space inside the frame of the jumbotron and remove it and insert what ever image you choose. In a moving image, the shape of the screen and position of the screen in the frame is changing in every frame if the camera is moving.You accomplish this difficult task by marking places in the frame that are always visible (bright white points usually) and then making sure they remain in place as the camera pans across or zooms out. Now that you've got the location of the anchor points, you create a mask that fits inside the screen area of the jumbotron and then make sure that mask is linked to those anchor points that are being tracked. That is called rotoscoping. Then you drop in your video and make it look like it was always there.For sure, that's a gross simplification, but I hope it gets the idea across.The new version of the Final Cut Suite (no number, should be #3 tho) include new feature updates for all the produces (except for DVD Studio Pro), but Philip was there to cover just Final Cut Pro 7.Because I clumsily referred to ProRez 422 in passing, give me a moment to explain what an intermediate codec is and what 422 color space and 4444 refers to.A color space is the limited range of color that can be viewed from the entire spectrum of color. Humans can see a wide swath of color between ultra violet and infra red (violet to red). Some insects and animals can see beyond that range. Mechanical devices, like monitors and cameras and capture and display color in a variety color spaces depending on type of color space. HSB (Hue Saturation and Brightness) is one space, RGB (Red, Green and Blue) is another.Video cameras generally use a color space called YCC, which is roughly RGB. The Y is the luma quality and the two Cs are the chroma, or color qualities. Those are the three values in a camera that shoots 4.2.2.Our eyes are more sensitive to luma than chroma, so in a 4.2.2 color space there's twice as much luma, or light, as there is color. Web and DVD video use a 4.2.0 space and the DV standard uses 4.1.1.Think of the 3 areas of information captured by a 4.2.2 camera as distinct channels of light or color. Like channels in photoshop. There is 4th channel of visual information which cameras won't capture because it is created in post production, the alpha channel.Alpha channels are used in Photoshop, After Effects and Final Cut Pro are an additional layer of information that can be used to remove areas of the frame so that something else can be seen through it. Or it can act as a selection area of a moving object in the frame so an effect or filter can be applied to it.Hold that thought for a moment and let me move on to a codec. Among other things, it's a software program that compresses a moving digital image. There are a variety of codecs that compress video as a camera records it, and decompresses it as a DVD player plays it. It's a lossy process, which means digital information is lost when it's compressed. The greater compression, the more minutes of video can be shushed into a gigabyte of storage space.Still with me?There are a lot of codecs out there and the variety is necessary because of how you're using them. Camera codecs need to compress data a certain way to retain the most information to fit on the storage medium, tape, drive or solid state card. Cameras are capturing video for one purpose only, to store it. You aren't using it, cutting it into pieces, so it can squeeze it really tight.Cutting video in a codec designed for camera capture, particularly HDV, is not a pleasure to cut. It's doable, but has problems that I'm not going to get into. If you're producing a feature length movie or TV video you want to work in a codec that will give you more freedom to edit. That's what an intermediate codec is.One codec for capture, another for playback (sometimes the same one) and one in-between for the edit. Prorez is an intermediate codec.You capture the video from the camera as you do normally, then select the footage in FCP and then convert it to a Prorez codec.Hang in there, I'm coming to the end.When you convert footage captured by a camera using a codec using the 4.1.1 or 4.2.0 color space to, say, Prorez 4.2.2, does that mean you're getting a better quality out of the footage you shot?No!Footage captured in every DV or HDV camera is being compressed on the fly using whatever color space the camera uses. That compress, being lossy discards anything that doesn't fit. So when you convert it to a high resolution color space, it's got a bunch space it isn't using. When you shake it, you can hear it rattle.So why would you convert it to the 4.2.2 space, or for that matter, 4.4.4?One reason is these other codecs have other characters that make it more efficient for your editing software to edit, render and export the video. More importantly though, and this IS the reason you would use Prorez 4x4 (4.4.4.4) is that anything else you add, a still image, motions graphics from After Effects or Motion, or 3D animation from Maya or 3D Studio Max will be added at their full, mostly likely higher color and image resolution.These additional elements, even something as simple as title text have to be massaged by various filters and often moved in and out of other programs to make them feel like they're as real as the realness of the video footage. Have a space that allows you to work with the maximum amount of resolution of color and pixel depth offers the kind of control the people with the big bucks are looking for.You and I are just lucky that we don't have to have big bucks to get into this party.As hard as that was to read, and I congratulate you if you got this far, it was no picnic figuring how to say it. And be careful, don't use this in your research paper.I'm not going to put links to all this stuff. I've put out the bare bones. If you need to know more you can look it up for yourself.I hope it's been useful.You can find pricing for educational software at Journey Ed and Academic Superstore. I've used them both and they're fast.Mike Jones at Digital Basin has a good review of the suite upgrade, including what's missing. And check out the Film School Drinking game which I found in the same article. It's an education in itself.Finally, if you're on the fence about getting the Snow Leopard update, Leo Laporte and his gang of usual suspects provide a definitve thrashing of the pros and cons in #156 of Macbreak Weekly.

Markertek News Channel coverage of the VC-50HD Field Recorder from Edirol at NAB 2009. The VC-50HD converts from HD-SDI to 50/ 35/ 8 Mbps MPEG-2 TS as well as HDV format (25/19Mbps). The unit also supports conversion from SD-SDI to DV format (25Mbps) and 12/ 9/ 2 Mbps MPEG-2 TS. The dedicated HDMI Output port provides display and monitoring of both the video and audio signal. The output can also be used to directly connect to a large display or video projector.The VC-50HD supports three different types of power supply: AC power adaptor, AA batteries, and external battery support. The built-in 8AA battery tray can supply seamless failover power should the AC power become disconnected or while changing over external battery packs. Additionally the VC-50HD can accept V-Mount and Gold Mount external batteries systems.

iLife ’09 (iPhoto, iMovie, iWeb) con Tanya Castañeda y Allan Tépper. Rafael Andreu de Ramm Animation: Liliana Marín y Allan Tépper conversan con él. Rubén Abruña y Allan Tépper revisitan las virtudes del HDV. Para escuchar esta emisión sola, haz … Continuar

Markertek News Channel coverage of the F-1 HDV/DV Video Field Recorder from Edirol at HD World 2008 -NYC. The EDIROL F-1 is the ideal addition for any videographer or producer wanting to accelerate their workflow by capturing HDV or DV directly to a hard drive in the field. With two additional audio inputs, no file size limitation, removable hard drive and multiple power options, the F-1 can be used anywhere and in a variety of applications.

Markertek News Channel coverage of the new EX 0.75X Aspheric Wide Converter from 16x9 Inc. at HD World 2008 -NYC. The EX 0.75 Aspheric Wide Converter-the first wide converter to bring the benefits of aspheric technology to DV and HDV cameras, is the top-quality optical solution for getting wider angle images from Sony's popular new PMW-EX1 and EX3 camcorders, the EX 0.75X provides a 25% greater angle of view while maintaining full zoom capability.

Day 2 & 1As a result of excellent feedback from Linda, my wife, I've made some significant changes to the order in which speakers are introduced. I had begun with discrete, self contained blocks, where an individual presents themselves. Of course I intended to mix individual's comments together where they touched on the same topic as the film progressed, but it was made clear to me through Linda's perspective that I could begin that earlier, so there wasn't an obvious transition from one person speaking at a time to many people speaking.It was a real structural problem for me and I'm grateful for the insight she provided. You know, I know what I want to do and could have acted alone, but I had nagging doubts that my perspective was too inside, too familiar to be trusted as far as how much I could ask the audience to accept as they were introduced to the film's characters and ideas. Things such as the pacing, I'm using a lot of rapid cuts. It really pays to have someone you can trust who can offer concise, intelligent comments.Day 1 ends and I still don't have the film transfered to tape. I spent a number of hours but between working with HD footage in Avid and moving it to HDV tape, or SD for that matter, there were lots of unresolved problems. And I lost a lot of editing time in the process.Not that this isn't my own fault for starting late in the first place.I mention a number of suggestions made by one of my constant instructors, Howard Phillips, for enhancing the movement of the story and I did a poor job of explaining J & L cuts, so follow the link to find out a little bit more. I've added them throughout the film to ease the audience from one cut to another. It's a subtle thing. The difference it makes is not so much what it adds, so much as what it removes, which is often an abrupt, gawky cut between two speakers, or scenes.Another point I missed in the excitement of reciting my day, is that the 90 second segment where I introduce a new character and I thought I was going to have to scrap it because I didn't have B-roll to cover several jump cuts. I forgot to mention the solution, which was to use dip-to-color between the cuts. It's only a second where the clip fades in, then out to black, but it heals the jump cut wound quite nicely.Now, I know how to do this and had used it sparingly in other parts of the film, but I thought it was too much in your face, it would be too jarring to the viewer if I did it several times within 90 seconds. I was assured by people whose opinions matter that it was fine and acceptable. I don't know if they meant in general, or under the circumstances of the looming deadline, but I gladly accepted it like a get out of jail card. We'll see how people react at the screening.

Whether to use the Canon XH-A1 or the Panasonic DVX200 is more than just HDV versus HD, or tape versus P2 solid state. It comes down to what you know, and I know the Panasonic better than the Canon. Brand wise, I'm all over Canon. The first film SLR I purchased with my own money was a Canon FTb. Tough as a tank; I loved that camera.It's just that I believe that it's easier to create when the tools being used are transparent, that is, they're so familiar that they're effortless to use, acting as an extension of your body. At this point I can't say this is true for any video camera I've used, but the Panasonic is the closest. In the show I give a little detail on the advantages it has over the Canon.One of them is the ability to shoot in true slow motion. I've put some examples on my YouTube page of slow motion and accelerated motion footage and as well as a video demonstrating rack focus.We've spent a lot of time in class reviewing the data forms we need to fill out to create our production book. The book, which is a collection of forms signed, lists of names and shots, drawings, sketches and other information that represents the roadmap to our final destination, the finished film. It's a work in progress, but we do have to something to show before the end of the module.Don't forget to send me questions you want answered while I'm at NAB, the National Association of Broadcasters conference, coming up in mid April. I'm available for meetups if you're in Las Vegas at the same time.

I'm having difficulty hunkering down on the edit for our third major film project which we call The Killer.  Ambivalence, apathy and fatigue I've made some comments about HDV again. Thanks to Mike Jones at Digital Basin for his comments, posted in the show notes of VSG #68 about the viability of editing HDV native in FCP. I'm realizing the importance of pre prod and especially previz in preparing for shoots. Getting enough coverage is increasingly a concern. We just never seem to get enough. It's not the quantity, but the quality, the number of different types and the exact type. FrameForge 3D is a previz tool that I have and I need to get to know it better. Take a look at the book, In the Blink of an Eye, by Walter Murch. It's a great read and a good introduction to editing.

This week we spent preparing for our first weekend of shooting. I've got some comments to pass along about how to work with the talent, especially if you're crew. We've also made our lives more difficult by not having put more time into preproduction. Everything is connected, from Producer to production assistant. Things go all bass ackward if you don't communicate . We're going to be using a Panasonic HVX200, which is an HD camera that has many benefits over the camera we've been using up to now, the Panasonic DVX100. The first thing is that the menu controls and switches on the outside are mostly the same, so the learning curve is limited to working with the media. The HVX can record to tape, but only standard definition. To record high definition you record to solid state memory cards, called P2 cards. Here are a few reasons on why HD is a better format: Images are 2 to 4 times the size of standard definitionThere is more color in the videoIt captures real slow motion and accelerated motionThe format is easy to transfer to drive, and easy to edit Disadvantages include: You can't capture to both tape and P2 card at the same timeThere is no archival medium in HD, you wipe the card and reuse it after you transfer it to your driveThe P2 card is expensiveThe life of a P2 card is unknownHD footage takes up 2 to 3 times more disk space In this episode I take a shot at explaining the difference between HD format and HDV format and frankly I don't think I made anything clear. It's useful to know, but not critical, so I'm going to lay it out here. If you need to know more, do some research on your own, otherwise, skip the next three paragraphs. HD and HDV are capture formats. They're good formats for compressing data so you can fit as much data as possible on what ever medium they require, HD requires P2 cards, HDV can use MiniDV tapes, same as for standard definition. Both HD and HDV record the same resolution, and for all I've been told, the same 4.2.2 color space. Standard definition video records in 4.1.1 color. What qualifies as  high end digital video, approaching film quality, is 4.4.4 color. I don't need to explain how it works, it's enough to understand that the capacity to capture all the available color is limited as you move from film, to HD, to SD. By the way, film is a poor second to the color capture capability of our own eyes. HDV cameras are less expensive than HD cameras for the reasons already mentioned in the advantage list above, real slow motion, etc. HD is easier to edit immediately after capture compared to HDV due to the different compression formats they each use. HDV captures footage in groups of 15 frames, called GOP - Group Of Pictures. The first frame contains all the picture information inside the frame, then each frame following that contains only those pixels that have changed. Take a picture of a wall with HDV and the first frame contains all the info, each of the following frames have no new information and so have no additional data. That keeps the file size down so it will fit on the the tape. If a person or even a fly moves through the frame every frame that records changed information has to record it, because it's not on the first frame. But only the pixels that changed need to be recorded. And thats fine until you need to edit the video. Then you find you can't cut inside the GOP sections, they're like a single unit. To get past this problem you need to convert the digital video to an intermediate codec that reconstitutes each frame, completely restoring the data to each frame. This of course makes the files larger, but that's the price you pay for editing this format on a digital nonlinear editor like Avid or Final Cut Pro. Next week we shoot the bar scene Saturday and Sunday.

Join Kevan O’Brien as he discusses how shooting progressive video rather than interlace video allows for higher quality and clearer/less noisy web video. By shooting progressive you reduce the amount of processing the encoder does, saving time and getting a resulting higher quality video for the bit rate. The Canon XH A1 is featured in this podcast, showing the capability of shooting in progressive mode at both DV and HDV quality, depending on how the video is to be further exploited beyond the web.

Live från Innovatum i Trollhättan - Filmbaren om produktion! Hur gör man det bästa av sin budget? Hur lång tid tar det att göra en långfilm och vad behöver det kosta egentligen? Hur funkar HDV i ett arbetsflöde för långfilm? Medverkande: Erik Zaring, Dockhus Animation (Desmond & Träskpatraskfällan), Robert Lillhonga (Hata Göteborg), Martin Jern, regissör (Fjorton suger, Du & jag), Emil Larsson, regissör (Fjorton suger, Du & jag). Moderator: Finn Hensner

Check out the latest hypest Down and Dirty DV Camera Guide featuring specs, prices, and commentary on some of the hottest DV and HDV cameras on the market. Don't buy or rent a camera without it! Subscribe to the Down and Dirty DV Nation mailing list to receive exclusive FREE updated Camera Guides as soon as they hit the streets. Go to DownAndDirtyDV.com for more FREE pages or to order a copy of the whole book... (277 pages, 200+ illustrations, $24.95) Stay tuned. More video podcasts are on the way! No fluff, no puff, no B.S.... just straight-up practical guerrilla filmmaking knowledge. Who loves you, Baby?... Down and Dirty DV, that's who.

Watch the videoExample of footage from the new Sony HDR-HC7 HDV Video Camera which just arrived in stores this week. Shot by Jeremy from the SonyHDVinfo.com Sony HDR-HC7 Forum in a suburb of Chicago 2.8.07. Thank you Jeremy. 14 second original H.264 export of native 1440x1080 HDV file from Final Cut Express HD was 165 MB. I ripped a DVD image from it with Toast 8 then crushed to a maximum iPod compatible size with Handbrake leaving only 4.2 MB. Still looks pretty darned good don't you think? Taylor Barcroft Santa Cruz CA

Underwater imager and writer, Eric Hanauer and nature imager and writer, Karen Straus dive with a mother Humpback Whale, her calf, and a male escort, off Roca Partida, a rocky island about 250 miles off the coast of Cabo San Lucas, Baja del Sur, Mexico. This is some of the most fantastic Humpback footage you'll ever see! Narrated by both Eric and Karen, who both also shot the HDV footage, as well as the accompanying still photographs, this film was one of the judges' and audience's favorites at the most recent San Diego UnderSea Film Exhibition. Beautifully edited by Eric. To learn more about Eric and see more of his work, please visit his website, EHanauer.com. Karen is a skilled bird photographer as well as an underwater imager of many years. You can see more of her work at her new website, BirdBrained.biz. DiveFilm Podcast Video is proud to announce that this film is the first one to be released as one of DiveFilm's new High Definition Video Podcasts and Web Videos. To learn more, visit DiveFilmHD.com.

Underwater imager and writer, Eric Hanauer and nature imager and writer, Karen Straus dive with a mother Humpback Whale, her calf, and a male escort, off Roca Partida, a rocky island about 250 miles off the coast of Cabo San Lucas, Baja del Sur, Mexico. This is some of the most fantastic Humpback footage you'll ever see! Narrated by both Eric and Karen, who both also shot the HDV footage, as well as the accompanying still photographs, this film was one of the judges' and audience's favorites at the most recent San Diego UnderSea Film Exhibition. Beautifully edited by Eric. To learn more about Eric and see more of his work, please visit his website, EHanauer.com. Karen is a skilled bird photographer as well as an underwater imager of many years. You can see more of her work at her new website, BirdBrained.biz. DiveFilm Podcast Video is proud to announce that this film is the first one to be released as one of DiveFilm's new High Definition Video Podcasts and Web Videos. To learn more, visit DiveFilmHD.com.

un court-métrage de Christian Laurence et Geneviève Perron en HDV

We are back after having Podcast Burnout, International Pauly gets hitched, The Messy Crusher, Simonsen has a busy month, Jack Elsegood is eligibile - but for what? Apple Noos and Nasty Batteries, Sony's new HDV cam, JP's mega burger tips, Rusty Sausage Fluffs Big Time, Special K Josh takes over the US meat pie market but still unable to get a real date, Coopers Balaklava Swim Thru, Linda down side up in Tassie, and more zany stuff